Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 21, Pages 4897
Publisher
MDPI AG
Online
2020-10-23
DOI
10.3390/molecules25214897
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications
- (2019) Jiaxin Liu et al. International Journal of Nanomedicine
- Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model
- (2018) Laurence A. Hutton-Smith et al. MOLECULAR PHARMACEUTICS
- Verteporfin Photodynamic Therapy for Subfoveal Choroidal Neovascularization in Pathologic Myopia: A 12-Month Retrospective Review
- (2018) C. Costagliola et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery Approaches
- (2018) Kelly M. Loyet et al. MOLECULAR PHARMACEUTICS
- Acid-Induced Intracellular Dissociation of β-Cyclodextrin-Threaded Polyrotaxanes Directed toward Attenuating Phototoxicity of Bisretinoids through Promoting Excretion
- (2017) Atsushi Tamura et al. MOLECULAR PHARMACEUTICS
- RISK FACTORS AND CLINICAL SIGNIFICANCE OF PRECHOROIDAL CLEFT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2017) Jong Min Kim et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
- (2017) Rupert R A Bourne et al. Lancet Global Health
- Anxiety levels and perceived pain intensity during intravitreal injections
- (2015) Ori Segal et al. ACTA OPHTHALMOLOGICA
- Current nanotechnology approaches for the treatment and management of diabetic retinopathy
- (2015) Joana F. Fangueiro et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Endothelial cell-targeted pVEGF165 polyplex plays a pivotal role in inhibiting intimal thickening after vascular injury
- (2015) Shouqin Tian et al. International Journal of Nanomedicine
- Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles
- (2012) Changyang Gong et al. BIOMATERIALS
- Mechanisms of Age-Related Macular Degeneration
- (2012) Jayakrishna Ambati et al. NEURON
- Integrin Targeted Therapeutics
- (2012) Melissa Millard et al. Theranostics
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Perspectives of Choroidal Neovascularization Therapy
- (2011) M. Caputo et al. CURRENT DRUG TARGETS
- A Pilot Study on the Combination Treatment of Reduced-Fluence Photodynamic Therapy, Intravitreal Ranibizumab, Intravitreal Dexamethasone and Oral Minocycline for Neovascular Age-Related Macular Degeneration
- (2011) S. Sivaprasad et al. OPHTHALMOLOGICA
- Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization
- (2010) Raimondo Forte et al. ACTA OPHTHALMOLOGICA
- Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab)
- (2010) David Ehmann et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Regression of Peripapillary Choroidal Neovascularization after Oscillatory Transpupillary Thermotherapy and Anti-VEGF Pharmacotherapy
- (2010) Gholam Peyman et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
- (2010) Napoleone Ferrara NATURE MEDICINE
- Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration
- (2009) Thomas A Ciulla et al. CURRENT OPINION IN OPHTHALMOLOGY
- Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study
- (2009) Raquel Costa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- SAME-DAY TRIPLE THERAPY WITH PHOTODYNAMIC THERAPY, INTRAVITREAL DEXAMETHASONE, AND BEVACIZUMAB IN WET AGE-RELATED MACULAR DEGENERATION
- (2009) SOPHIE J. BAKRI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Subfoveal choroidal neovascularization complicating 25-gauge trans-retinal choroidal tumor biopsy
- (2008) Martina Angi et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Age-Related Macular Degeneration
- (2008) Rama D. Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vascular endothelial growth factor in eye disease
- (2008) J.S. Penn et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Central serous chorioretinopathy
- (2007) Maria Wang et al. ACTA OPHTHALMOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now